CDE Detailed Report
Disease: Sickle Cell Disease
Sub-Domain: Assessments and Examinations
CRF: PhenX Toolkit: Bilirubin level

3 results.
CDE ID CDE Name Variable Name Definition Short Description Additional Notes (Question Text) Permissible Values Description Data Type Disease Specific Instructions Disease Specific Reference Population Classification (e.g., Core) Version Number Version Date CRF Name (CRF Module / Guideline) Sub Domain Name Domain Name Size Input Restrictions Min Value Max Value Measurement Type Source Form Set Form Field
C58742 Bilirubin most recent direct measurement BlrubinMstRcntDrctMeasr Measurement in milligrams per deciliter for the most recent direct measurement of bilirubin. Measurement in milligrams per deciliter for the most recent direct measurement of bilirubin. Bilirubin level Numeric Values PhenX Measure: Bilirubin Level (#810900) Adult;Pediatric Proposed 1.00 2018-12-07 13:01:37.0 PhenX Toolkit: Bilirubin level Assessments and Examinations Laboratory Tests and Biospecimens/Biomarkers

Free-Form Entry

0 9.9 milligram per deciliter BMTCTN 1507A Release 5.10 1507A (ENR) HSCBILI
C59176 Hemophilia indicate code HemophiliaIndicateCode Code indicating whether the subject/participant has hemophilia. Code indicating whether the subject/participant has hemophilia. Do you have hemophilia? 1;2;7;9 Yes;No;Refused;Don't know Numeric Values

If the subject/participant answers "Yes", he/she is excluded from the blood draw. If he/she answers "No" or "Don't know," blood is drawn from him/her.

Adult;Pediatric Proposed 1.00 2019-03-26 12:31:08.0 PhenX Toolkit: Bilirubin level Assessments and Examinations Laboratory Tests and Biospecimens/Biomarkers

Single Pre-Defined Value Selected

PhenX Specialty Collection_Cardio-Pulm-Renal AST level 1
C59177 Cancer chemotherapy past or next four weeks indicate code CncrChemoPstOrNxt4WkIndCode Code indicating whether the subject/participant has had cancer chemotherapy in the past four weeks or anticipates having it in the next four weeks. Code indicating whether the subject/participant has had cancer chemotherapy in the past four weeks or anticipates having it in the next four weeks. Have you received cancer chemotherapy in the past four weeks or do you anticipate such therapy in the next four weeks? 1;2;7;9 Yes;No;Refused;Don't know Numeric Values

If the subject/participant answers "Yes," he/she is excluded from the blood draw. If he/she answers "No" or "Don't know," blood is drawn from him/her.

Adult;Pediatric Proposed 1.00 2019-03-26 12:35:43.0 PhenX Toolkit: Bilirubin level Assessments and Examinations Laboratory Tests and Biospecimens/Biomarkers

Single Pre-Defined Value Selected

PhenX Specialty Collection_Cardio-Pulm-Renal AST level 2
3 results.
CSV